Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Ramya Kongala"'
Autor:
Kyle G. Williams, Ramya Kongala, Donna M. Shows, Andrew J. Konecny, Duncan C. Hindmarch, Astrid S. Clarke, James D. Lord
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 17, Iss 1, Pp 119-130 (2024)
Background & Aims: Inflammatory bowel disease (IBD) causes a marked increase in the number of T cells in the intestinal mucosa. Debate exists about whether these excess cells arise from local clonal proliferation or recruitment from the periphery. Me
Externí odkaz:
https://doaj.org/article/ee9454018c844a7b80fe3559c671e348
Publikováno v:
Inflammatory Bowel Diseases. 29:S80-S81
BACKGROUND Inflammatory bowel disease (IBD) causes T cell infiltration of the intestinal mucosa, but the heterogeneity of these cells is not understood at a clonal level. The drug vedolizumab is believed to treat IBD by blocking the entry of circulat
Publikováno v:
The Journal of Immunology. 208:48.14-48.14
Vedolizumab blocks integrin alpha4/beta7 interaction with MAdCAM-1 on intestinal vascular endothelial cells. It is believed to treat inflammatory bowel disease (IBD) by preventing alpha4/beta7+ cells in blood from entering the intestinal mucosa. By C
Publikováno v:
Gastroenterology. 162:S-49
Autor:
James D. Lord, Mara Monetti, Flora Martz, Ramya Kongala, Caitlyn Dickinson, Jeffrey A. Culver, Isac Lee, Scott Jelinsky, Marion Kasaian
Publikováno v:
Gastroenterology. 162:S-517
Autor:
Boden, Elisa K, Kongala, Ramya, Hindmarch, Duncan C, Shows, Donna M, Juarez, Julius G, Lord, James D
Publikováno v:
Inflammatory Bowel Diseases; May2024, Vol. 30 Issue 5, p704-717, 14p
Publikováno v:
Gastroenterology Week; 1/9/2024, p19-19, 1p
Publikováno v:
Gastroenterology Week; 1/2/2024, p744-744, 1p
Publikováno v:
Immunotherapy Weekly; 10/31/2023, p1024-1024, 1p